Stifel Nicolaus Has Lowered Expectations for DENTSPLY SIRONA (NASDAQ:XRAY) Stock Price

Key Points

• Stifel Nicolaus has reduced its price target for DENTSPLY SIRONA from $19.00 to $17.00, maintaining a "hold" rating.
• Despite the downgrade, the new target suggests a potential upside of 33.39% from the stock's current trading price.
• DENTSPLY SIRONA reported earnings of $0.52 per share for the previous quarter, slightly surpassing analysts' expectations.

DENTSPLY SIRONA (NASDAQ:XRAY - Free Report) had its price objective decreased by Stifel Nicolaus from $19.00 to $17.00 in a research note issued to investors on Friday,Benzinga reports. Stifel Nicolaus currently has a hold rating on the medical instruments supplier's stock.

Other equities research analysts also recently issued reports about the stock. UBS Group decreased their target price on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a "buy" rating for the company in a research report on Friday, May 9th. Barrington Research reissued an "outperform" rating and issued a $21.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, July 22nd. Morgan Stanley cut DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price on the stock. in a research report on Tuesday, April 15th. Piper Sandler decreased their price target on DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a report on Wednesday, April 30th. Finally, Wall Street Zen upgraded DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Sunday, July 13th. Twelve equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $18.64.

DENTSPLY SIRONA Trading Up 4.2%

NASDAQ XRAY traded up $0.53 during trading hours on Friday, hitting $13.05. 3,423,176 shares of the company's stock were exchanged, compared to its average volume of 2,996,652. The stock has a 50-day simple moving average of $15.64 and a 200 day simple moving average of $15.82. DENTSPLY SIRONA has a 1-year low of $12.16 and a 1-year high of $27.48. The firm has a market cap of $2.60 billion, a price-to-earnings ratio of -2.75, a PEG ratio of 0.80 and a beta of 0.94. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.02. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%. The business had revenue of $936.00 million for the quarter, compared to analyst estimates of $929.67 million. During the same quarter in the prior year, the company earned $0.49 earnings per share. The company's quarterly revenue was down 4.9% on a year-over-year basis. On average, equities analysts forecast that DENTSPLY SIRONA will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Shareholders of record on Friday, September 26th will be given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 4.9%. The ex-dividend date of this dividend is Friday, September 26th. DENTSPLY SIRONA's dividend payout ratio (DPR) is currently -13.50%.

Institutional Trading of DENTSPLY SIRONA

Large investors have recently bought and sold shares of the company. Treasurer of the State of North Carolina boosted its stake in DENTSPLY SIRONA by 0.6% during the fourth quarter. Treasurer of the State of North Carolina now owns 88,854 shares of the medical instruments supplier's stock valued at $1,686,000 after buying an additional 560 shares during the period. Quarry LP boosted its stake in DENTSPLY SIRONA by 25.7% during the fourth quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier's stock valued at $72,000 after buying an additional 780 shares during the period. Public Employees Retirement System of Ohio boosted its stake in DENTSPLY SIRONA by 1.4% during the second quarter. Public Employees Retirement System of Ohio now owns 61,873 shares of the medical instruments supplier's stock valued at $983,000 after buying an additional 861 shares during the period. Federated Hermes Inc. boosted its stake in DENTSPLY SIRONA by 0.5% during the fourth quarter. Federated Hermes Inc. now owns 169,304 shares of the medical instruments supplier's stock valued at $3,213,000 after buying an additional 915 shares during the period. Finally, Gabelli Funds LLC boosted its stake in DENTSPLY SIRONA by 1.0% during the first quarter. Gabelli Funds LLC now owns 98,000 shares of the medical instruments supplier's stock valued at $1,464,000 after buying an additional 1,000 shares during the period. 95.70% of the stock is owned by hedge funds and other institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.